OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Gopika G. Nair, Emmanuel S. Tzanakakis, Matthias Hebrok
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 9, pp. 506-518
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2589-2625
Open Access | Times Cited: 404

Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Xiaomo Wu, Ju Jiang, Zhongkai Gu, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 222

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetologia (2021) Vol. 64, Iss. 12, pp. 2609-2652
Open Access | Times Cited: 221

Generation of insulin-producing pancreatic β cells from multiple human stem cell lines
Nathaniel J. Hogrebe, Kristina G. Maxwell, Punn Augsornworawat, et al.
Nature Protocols (2021) Vol. 16, Iss. 9, pp. 4109-4143
Open Access | Times Cited: 119

Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates
Yuanyuan Du, Zhen Liang, Shusen Wang, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 272-282
Closed Access | Times Cited: 97

Towards a better understanding of diabetes mellitus using organoid models
Belin Selcen Beydag-Tasöz, Siham Yennek, Anne Grapin‐Botton
Nature Reviews Endocrinology (2023)
Open Access | Times Cited: 40

Engineering islets from stem cells for advanced therapies of diabetes
Johanna Siehler, Anna Karolina Blöchinger, Matthias Meier, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 920-940
Closed Access | Times Cited: 96

Stem Cell-Based Clinical Trials for Diabetes Mellitus
Eleonora de Klerk, Matthias Hebrok
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 95

Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 94

The discovery of insulin revisited: lessons for the modern era
Gary F. Lewis, Patricia L. Brubaker
Journal of Clinical Investigation (2021) Vol. 131, Iss. 1
Open Access | Times Cited: 64

The Human Islet: Mini-Organ With Mega-Impact
John T. Walker, Diane C. Saunders, Marcela Briššová, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 605-657
Open Access | Times Cited: 64

Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges
Isaura Beatriz Borges Silva, Camila Harumi Kimura, Vitor Prado Colantoni, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38

Oral glucose-responsive nanoparticles loaded with artemisinin induce pancreatic β-cell regeneration for the treatment of type 2 diabetes
Jiapeng Chen, Yiyan Guo, Yuxin Zheng, et al.
Journal of Colloid and Interface Science (2025) Vol. 684, pp. 769-782
Closed Access

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
Wanling Lu, Lifang Xie, Yanhan Zhang, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 17

Development of a scalable method to isolate subsets of stem cell-derived pancreatic islet cells
Audrey V. Parent, Sudipta Ashe, Gopika G. Nair, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 4, pp. 979-992
Open Access | Times Cited: 25

Macroencapsulation Devices for Cell Therapy
Wei Liu, Yanfang Wang, Jinqiang Wang, et al.
Engineering (2022) Vol. 13, pp. 53-70
Open Access | Times Cited: 22

Light-stimulated insulin secretion from pancreatic islet-like organoids derived from human pluripotent stem cells
Jieun Choi, Eunji Shin, Jinsu Lee, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1480-1495
Closed Access | Times Cited: 13

Cytosolic pH is a direct nexus in linking environmental cues with insulin processing and secretion in pancreatic β cells
Yujiang Fang, Hexi Feng, Bowen Zhang, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1237-1251.e4
Closed Access | Times Cited: 3

Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Nishith R. Reddy, Hasna Maachi, Yini Xiao, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 3

The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
Sabine Szunerits, Sorin Melinte, Alexandre Barras, et al.
Chemical Society Reviews (2020) Vol. 50, Iss. 3, pp. 2102-2146
Closed Access | Times Cited: 37

Targeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges
Wenrui Wang, Chuan Zhang
Endocrine Connections (2021) Vol. 10, Iss. 8, pp. R213-R228
Open Access | Times Cited: 28

Single‐Domain Multiferroic Array‐Addressable Terfenol‐D (SMArT) Micromagnets for Programmable Single‐Cell Capture and Release
Reem Khojah, Zhuyun Xiao, Mohanchandra K. Panduranga, et al.
Advanced Materials (2021) Vol. 33, Iss. 20
Closed Access | Times Cited: 26

Pancreas agenesis mutations disrupt a lead enhancer controlling a developmental enhancer cluster
Irene Miguel-Escalada, M.A. Maestro, Diego Balboa, et al.
Developmental Cell (2022) Vol. 57, Iss. 16, pp. 1922-1936.e9
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top